Literature DB >> 10479155

The effect of doxycycline treatment on the development of protective immunity in a murine model of chlamydial genital infection.

H Su1, R Morrison, R Messer, W Whitmire, S Hughes, H D Caldwell.   

Abstract

Chlamydia trachomatis is a major cause of sexually transmitted disease (STD) worldwide. Antibiotics are effective in treating infection; however, reinfection is common. This observation has led to the conclusion that infection fails to elicit a protective antichlamydial immune response. It was postulated that high reinfection rates might be due to early eradication of organisms from genital tissue after antibiotic intervention, which could negatively influence the development of naturally acquired protective immunity. This hypothesis was tested by use of a murine model of female genital infection. The findings show that doxycycline intervention of infection, although very effective in eradicating chlamydiae from genital tissue and preventing upper genital tract disease, significantly inhibits the development of protective immunity. If antibiotic intervention of human chlamydial genital infection has a similar effect on protective immunity, it could have important implications in the understanding of immunity to infection and future public health efforts to control chlamydial STD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10479155     DOI: 10.1086/315046

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  48 in total

1.  The recall response induced by genital challenge with Chlamydia muridarum protects the oviduct from pathology but not from reinfection.

Authors:  Melissa M Riley; Matthew A Zurenski; Lauren C Frazer; Catherine M O'Connell; Charles W Andrews; Margaret Mintus; Toni Darville
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

2.  Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.

Authors:  Ashlesh K Murthy; James P Chambers; Patricia A Meier; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

Review 3.  Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies.

Authors:  Byron E Batteiger; Fujie Xu; Robert E Johnson; Michael L Rekart
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

4.  Modeling the transcriptome of genital tract epithelial cells and macrophages in healthy mucosa versus mucosa inflamed by Chlamydia muridarum infection.

Authors:  Raymond M Johnson; Micah S Kerr
Journal:  Pathog Dis       Date:  2015-10-29       Impact factor: 3.166

Review 5.  The immune response and antibacterial therapy.

Authors:  Olachi Anuforom; Graham R Wallace; Laura V Piddock
Journal:  Med Microbiol Immunol       Date:  2014-09-05       Impact factor: 3.402

6.  Murine models of Chlamydia trachomatis genital tract infection: use of mouse pneumonitis strain versus human strains.

Authors:  S A Morré; J M Lyons; J I Ito
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 7.  Strategies to control trachoma.

Authors:  Anu A Mathew; Angus Turner; Hugh R Taylor
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

8.  Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection.

Authors:  William M Geisler; Shelly Y Lensing; Christen G Press; Edward W Hook
Journal:  J Infect Dis       Date:  2013-03-07       Impact factor: 5.226

9.  IL-23 induces IL-22 and IL-17 production in response to Chlamydia muridarum genital tract infection, but the absence of these cytokines does not influence disease pathogenesis.

Authors:  Lauren C Frazer; Amy M Scurlock; Matthew A Zurenski; Melissa M Riley; Margaret Mintus; Derek A Pociask; Jeanne E Sullivan; Charles W Andrews; Toni Darville
Journal:  Am J Reprod Immunol       Date:  2013-12       Impact factor: 3.886

10.  Immunobiological outcomes of repeated chlamydial infection from two models of within-host population dynamics.

Authors:  David M Vickers; Qian Zhang; Nathaniel D Osgood
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.